AffiAB® Anti-Daxx Antibody [SC54-06]
Activation of the cell surface receptor FAS by FAS ligand leads to the initiation of apoptosis, a process necessary for the regulation of the immune system and tissue homeostasis. FAS-mediated apoptosis appears to involve a number of divergent and overlapping pathways. Daxx appears to be a central component of a FAS-mediated apoptotic pathway involving the activation of Jun N-terminal kinase (JNK) . Although Daxx itself does not contain a death domain, it specifically binds to the death domain of FAS. Overexpression of Daxx activates the JNK pathway and enhances FAS-mediated apoptosis. The Daxx apoptotic pathway acts cooperatively with but is distinct from the FAS-mediated pathway that involves interactions between the death domain-containing protein FADD and the cysteine protease FLICE. Unlike the FAS-FADD-FLICE pathway, the Daxx pathway is sensitive to the apoptotic inhibitor protein Bcl-2.
Antibody type
Recombinant Rabbit monoclonal Antibody
Uniprot ID
SwissProt: Q9UER7 Human
Recombinant
YES
Conjugation
Non-conjugated
Host
Rabbit
Isotype
IgG
Clone
SC54-06
KO/KD
N/A
Species reactivity
Human
Tested applications
WB, IF-Cell, FC
Predicted species reactivity
N/A
Immunogen
Recombinant protein within Human Daxx aa 195-313 / 740.
Storage
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
1*TBS (pH7.4) , 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
1 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
Apotosis, MAPK signaling pathway, Parkinson’s disease, Amyotrophic lateral sclerosis
Recommended dilutions
WB: 1:1, 000-1:2, 000; IF-Cell: 1:50-1:200; FC: 1:50-1:100
Molecular Weight
81 kDa
Subcellular location
Cytoplasm, Nucleus, Chromosome.
Positive control
PANC-1, A549, Hela, SW480.